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ABSTRACT
Recent technological advances have led to a rapid increase in alternative listening devices to conven-
tional hearing aids. The aim was to systematically review the existing evidence to assess the effectiveness
of alternative listening devices in adults with mild and moderate hearing loss. A systematic search strat-
egy of the scientific literature was employed, reported in accordance with the Preferred Reporting Items
for Systematic reviews and Meta-analyses (PRISMA) checklist. Eleven studies met eligibility for inclusion:
two studies evaluated personal sound amplification products, and nine studies assessed remote micro-
phone systems (frequency modulation, Bluetooth, wireless). The evidence in this review suggests that
alternative listening devices improve behavioural measures of speech intelligibility relative to unaided
and/or aided conditions. Evidence for whether alternative listening devices improve self-reported out-
comes is inconsistent. The evidence was judged to be of poor to good quality and subject to bias due to
limitations in study design. Our overall recommendation is that high-quality evidence (i.e. randomised
controlled trials) is required to demonstrate the effectiveness of alternative listening devices. Such evi-
dence is not currently available and is necessary to guide healthcare commissioners and policymakers
when considering new service delivery models for adults with hearing loss.
Review registration: Prospective Register of Systematic Reviews (PROSPERO), CRD42015029582
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Introduction
Acoustic amplification provided by hearing aids is currently the
primary clinical management strategy for adults with mild and
moderate hearing loss. Hearing aids have been shown to improve
hearing-specific health-related quality of life, general health-
related quality of life and listening abilities (Ferguson et al.
2017). However, two out of three people who would benefit
from using hearing aids do not take them up (Davis et al. 2007).
For those who do obtain hearing aids, estimates of non-use vary
from 3 to 24% (Ferguson et al. 2017). People with hearing loss
report that they are concerned or embarrassed that hearing aids
will make them look old and that they will be treated differently
by others (Barker, Leighton, and Ferguson 2017; Heffernan et al.
2016; Wallhagen 2010). For these reasons, alternative devices to
hearing aids and alternative service delivery models should be
considered as a potential means to increase patient choice, acces-
sibility to and acceptability of hearing services for people with
hearing loss that currently do not, or cannot, access hearing aids.
Whether new technologies can replace hearing aids has been
ranked by patients and the public as the fifth topmost research
priority for adults with mild to moderate hearing loss (Henshaw
et al. 2015). Indeed, advances in technology have led to a rapid
increase of alternative devices to conventional hearing aids. Here,
we define alternative listening devices as standalone products
that provide amplification of sound (e.g. Smartphone hearing aid
applications; personal sound amplification products; hearables),
as well as assistive listening devices (ALDs) that amplify and
transmit sound directly into hearing aids (e.g. Smartphone-con-
nected hearing aids; remote microphone systems). Many alterna-
tive listening devices can link wirelessly to Smartphone
technologies, allowing users to adjust and personalise their hear-
ing settings (e.g. gain, frequency response) in different listening
situations at their own convenience via an application (or app),
and without the need to visit a qualified clinician (Taylor 2015).
Existing evidence is mixed in terms of whether alternative lis-
tening devices are a suitable management strategy for hearing
loss. For example, ‘mid-range’ (US$100–$500) personal sound
amplification products (PSAPs), a type of ‘direct-to-consumer’
hearing device, have been shown to provide comparable electroa-
coustic characteristics (i.e. meet gain and output targets using
National Acoustic Laboratories prescriptive procedures) to hear-
ing aids (Callaway and Punch 2008). By comparison, other prod-
ucts defined as ‘low-cost’ (<US$100) may be of limited benefit
and potentially damaging to residual hearing due to over-ampli-
fication (Callaway and Punch 2008; Chan and McPherson 2015).
Smartphone-based ‘hearing aid’ apps have also been shown to
provide similar levels of amplification, improved speech-in-noise
performance and greater self-reported benefit in comparison to
hearing aids (Amlani et al. 2013). Remote microphone systems
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have also been shown to improve hearing outcomes, but may
require additional audiological support for optimal use
(Boothroyd 2004).
To date, no systematic review has evaluated whether alterna-
tive listening devices are a clinically effective intervention for
people with mild and moderate hearing loss. A systematic review
with meta-analysis provides the gold-standard evidence-base to
inform future feasibility and effectiveness trials of alternative lis-
tening devices. This approach is consistent with the Medical
Research Council’s guidelines for evaluating complex healthcare
interventions (Medical Research Council 2006). The primary
objective of this study, therefore, was to review and synthesise
the existing body of evidence to assess the effectiveness of alter-
native listening devices to conventional hearing aids.
Methods
Prior to commencing the systematic review, the protocol was
registered with the International Prospective Register of
Systematic Reviews (PROSPERO) (registration number,
CRD42015029582) and published in a peer-reviewed publication
(Maidment et al. 2016). Methods are reported according to the
Preferred Reporting Items for Systematic reviews and Meta-anal-
yses (PRISMA) checklist (Moher et al. 2009).
Eligibility criteria
The criteria for inclusion in the review were specified in terms
of participants, intervention, comparators, outcomes and study
designs (PICOS) as follows.
Participants
Adults (18 years) with a mild and moderate hearing loss (aver-
age hearing threshold across octave frequencies 0.25–4 kHz 20
and 70 dB HL (British Society of Audiology 2011). Studies that
included both children (<18 years) and adults were not included
unless data were reported separately. If the hearing thresholds
were not specified, the study author was contacted for further
clarification. If hearing threshold data was not reported and
could not be obtained, studies were included where the mean
average hearing threshold reported fell within the range of either
mild (between 20 and 40 dB HL) or moderate hearing loss
(between 41 and 70 dB HL). Bilateral and unilateral sensori-
neural, conductive and mixed hearing losses were included.
Intervention(s)
An alternative listening device to a conventional hearing aid was
considered to be non-medical standalone product (e.g.
Smartphone app, PSAP, hearable) or an assistive listening device
that provides additional functionality to a conventional hearing
aid (e.g. remote microphone system; Smartphone-connected hear-
ing aid whereby the Smartphone can be used as a remote micro-
phone and/or allows manipulation of gain and frequency response
via an app). An alternative listening device should aim to improve
hearing and communication outcomes in people with hearing
loss, specifically via the amplification of external sound sources.
Comparators
The comparisons of interest were either passive (e.g. unaided) or
active control (e.g. conventional hearing aid). A conventional
hearing aid was defined as a device that detects and amplifies
sound, delivering an amplified acoustic signal via air conduction
to the external auditory canal on the same side that the signals
are detected, irrespective of where it is worn (behind-the-ear, in-
the-ear or receiver-in-the-canal). Studies evaluating analogue
hearing aids were excluded.
Outcomes
As the aim of the review was to assess the clinical-effectiveness
of alternative listening devices, studies were restricted to out-
comes associated with the consequences of hearing loss. There
were no restrictions as to the duration of follow-up. Primary
outcomes included one or more of the following: (i) behavioural
measures of speech intelligibility (e.g. intelligibility of syllables,
words or sentences presented in quiet or in noise); (ii) hearing-
specific health-related quality of life (QoL), where participation
was the key domain, measured using any self-reported question-
naire (e.g. Hearing Handicap Inventory for the Elderly: Ventry
and Weinstein 1982) and (iii) adverse effects of patient, reported
as pain, discomfort, tenderness, skin irritation or ear infection as
a consequence of device fitting. Secondary outcomes included
any of the following self-reported outcomes: (i) General health-
related QoL (e.g. Health Utilities Index Mark 3: Furlong et al.
2001); (ii) listening ability (e.g. Abbreviated Profile of Hearing
Aid Benefit: Cox and Alexander 1995); (iii) cognition (e.g. work-
ing memory); (iv) feasibility (e.g. usability, adherence); (v)
adverse effect of noise-induced hearing loss (e.g. due to over-
amplification from inappropriate hearing aid fitting).
Study designs
Retrospective or prospective studies, randomised controlled trials,
non-randomised controlled trials, before and after studies were
included. Articles reporting expert opinions, practice guidelines,
case reports, case series, conference abstracts and book chapters
were excluded.
Search strategy
An initial literature search was conducted by a medical informa-
tion specialist (Farhad Shokraneh, University of Nottingham) on
2 April 2016. Searches were last updated on 7 March 2018 to
ensure that any newly published studies were included. The fol-
lowing databases were searched: CINAHL (via EBSCO host),
Cochrane Library, EMBASE (via Ovid SP), MEDLINE (via Ovid
SP), PubMed, Scopus, Citations Indexes of Web of Science,
ISRCTN Registry, ClinicalTrials.Gov and WHO International
Clinical Trials Registry Platform. Supplemental 1 provides full
electronic search strategies for all databases. All database searches
were completed in one day and with no time, language, docu-
ment type or publication status limitations. The search terms
were collected based on free text and controlled vocabularies
(Medical Subject Headings, Excerpta Medica Tree and CINHAL
Headings), expert opinion, literature review and checking the
test search results.
Additional information was identified manually through
snowballing of the reference lists from included studies, as well
as screening of related articles by shortlisted authors to identify
any relevant articles that may not have been returned by the ini-
tial database searches. Contact with study authors was not neces-
sary to ascertain whether any studies were ongoing.
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Study selection
Two investigators (DM, AB) independently screened all identi-
fied references to decide eligibility according to the PICOS crite-
ria by reading the title and/or abstract. The full text was
obtained for articles that appeared to meet eligibility or where
there was any uncertainty (i.e. insufficient information to make a
clear decision). We did not need to contact study authors for
additional information to resolve questions concerning eligibility.
Discrepancies were resolved through discussion between
investigators.
Data collection process
A standardised data collection form constructed via Covidence
(www.covidence.org) was used, which included study details (e.g.
sponsorship source, country, setting), author’s contact details
(name, institution, email, postal address), study design, popula-
tion (inclusion/exclusion criteria, baseline characteristics), inter-
ventions (and comparators) and outcomes. Prior to starting the
review, detailed guidance notes were devised by DM and were
piloted by DM and AB to ensure consistency. Data collection
was conducted by DM and AB independently, but in duplicate
for every included record. Where necessary, study authors were
contacted to resolve any uncertainties and to obtain any missing
data. If data could not be obtained and were only presented in
graphical form, the results were estimated from figures using
WebPlotDigitizer (http://arohatgi.info/WebPlotDigitizer/app/).
Disagreements about numerical data extracted from figures were
discussed and resolved by averaging.
Risk of bias in individual studies
DM and AB independently assessed risk of bias of each included
study with the Cochrane risk of bias tool (Higgins and Green
2011), which rates the studies as ‘high risk’, ‘low risk’ or ‘unclear
risk’ in the following six domains: sequence generation, alloca-
tion concealment, blinding of participants and personnel, blind-
ing outcome assessors, incomplete outcome data, selective
outcome reporting and other sources of bias (e.g. influence of
funders). As all included studies were non-randomised, the
Downs and Black (1998) checklist, which consists of 27 criteria,
was used to assess study quality. Criterion 27 was adapted to
consider whether or not a power calculation was performed
rather than whether there was sufficient power to detect a clinic-
ally meaningful change, as there is a lack of consensus regarding
clinically meaningful change in hearing loss outcome measure-
ment (Barker et al. 2016). All answers were scored 0 (‘no’ or
‘unable to determine) or 1 (‘yes’), with the exception of criterion
5 (‘Are the distributions of principal confounders in each group
of subjects to be compared clearly described?’), which was scored
0 (‘no’), 1 (‘partially’) or 2 (‘yes’). The total maximum score was
28, with study quality rated as excellent (26–28), good (20–25),
fair (15–19) or poor (14) (Hooper et al. 2008).
Data synthesis
Included studies were reviewed in order to determine whether
their data were suitable for inclusion in the meta-analyses. Meta-
analyses were only performed when studies were broadly compar-
able in terms of study design, interventions and outcomes. For
continuous data, where the studies used the same outcome meas-
ure, mean differences (MDs) were calculated with 95% confidence
intervals (CI). If different outcome measures were employed,
effect sizes were calculated as standardised mean differences
(SMDs) in which the mean difference between conditions was
divided by the pooled standard deviation (between-group) or by
the standard deviation of the differences (within-group).
Heterogeneity in effect sizes across studies was examined using
the I2 statistic and its significance was tested using a v2 test.
This approach to quantifying heterogeneity provided a value
from 0 to 100%, with low (0–40%), medium (41–60%) and high
(61–100%) ranges (Higgins and Green 2011). In the absence of
meta-analysis, primary and secondary outcomes were assessed
at the individual study level through narrative synthesis (Popay
et al. 2006).
Deviations from the published protocol
Although we pre-specified that the data would be subjected to
both random and fixed effects models, we opted to only use a
random-effects meta-analysis. A random effects approach was
considered most appropriate based on an assumption that effect
sizes would vary across studies, not only because they used dif-
ferent samples of participants (as assumed in a fixed effect
approach) but also due to differences in assessment methodolo-
gies employed. In addition, we stated previously that we would
not pool studies if I2 exceeded 60%, suggestive of high hetero-
geneity (Higgins and Thompson 2002). However, although het-
erogeneity was high, which was to be expected due to differences
across studies, we thought it useful to illustrate the pooled data
for comparable studies irrespective of heterogeneity but took this
into account when interpreting the data.
Results
A total of 2198 records were identified for screening. Following
the removal of 1060 duplicate publications, 1138 records were
subjected to a three-stage screening process (Figure 1). The full
texts of 149 articles that passed the initial title and abstract
screen were retrieved. A total of 138 articles were not judged to
have met inclusion criteria and were excluded. Eleven studies
were included in the review.
Supplemental 2 summarises the characteristics of the 11 stud-
ies included in the review. Two categories of alternative listening
device (i.e. intervention) were evaluated, (i) PSAPs (n¼ 2); and
(ii) remote microphone systems (n¼ 9). All studies were before-
after comparisons, with participants acting as their own control.
Comparators included unaided, conventional hearing aids alone
or another alternative listening device. Four studies assessed out-
comes at a range of follow-up durations, from one month (Sacco
et al. 2016) to one year (Chisolm et al. 2007). For studies that
were sufficiently similar in terms of interventions and outcomes,
meta-analyses were performed. Narrative synthesis (Popay et al.
2006) are reported where meta-analyses were not possible.
PSAPs
Speech intelligibility
Two eligible studies (n¼ 73 participants) assessed six different
PSAPs. Sacco et al. (2016) evaluated the TEO First listening
device (Tinteo, Personal Sound Society), classified by the authors
as an ‘over-the-counter’ hearing device. Reed et al. (2017)
assessed five different PSAPs, which varied in terms of the pur-
chase price as of 4 July 2017.
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PSAPs vs. unaided. Summary effects and forest plots are pro-
vided in Supplemental 3 and Figure 2 respectively. Overall per-
formance across both studies was better when using a PSAP
relative to unaided conditions (Figure 2(A)). Heterogeneity was
low (I2¼ 0%). To provide a conservative estimate of effect, per-
formance in Reed et al.’s (2017) study was pooled across all five
included PSAPs. However, Reed et al. (2017) also showed that,
in comparison to unaided, performance was superior for PSAPs
that were pricedUS$299.99 (Reed et al. 2017).
PSAPs vs. hearing aids. Only one study (n¼ 42 participants)
compared PSAPs with conventional hearing aids (Reed et al.
2017). This showed an effect favouring hearing aids compared to
PSAPs that were pricedUS$269.99. However, performance did
not differ statistically between hearing aids and PSAPs that were
pricedUS$299.99.
Hearing-specific health-related QoL
Hearing-specific health-related QoL was only reported by Sacco
et al. (2016) (n¼ 31 participants), who administered the Glasgow
Hearing Aid Benefit Profile (GHABP) handicap subscales.
Handicap scores reported as percentage change, decreased for
the TEO First device relative to unaided handicap for following
two items, (i) having a conversation without background noise
(–9.6%, p¼ 0.018), and (ii) having a conversation with several
people (–16.2%, p¼ 0.008).
Listening ability
Listening abilities were only reported by Sacco et al. (2016),
whereby statistically significant decreases in GHABP residual dis-
ability subscale scores (percentage change) were found for the
TEO First device compared to unaided disability for the
following four items: (i) watching television (–18.5%, p¼ 0.011),
(ii) having a conversation without background noise (–16.5%,
p¼ 0.002), (iii) having a conversation in noisy background
(–17.1%, p¼ 0.027) and (iv) having a conversation with several
people (–20%, p¼ 0.014).
Feasibility
Sacco et al. (2016) assessed device acceptability using a six-point
Likert scale, from zero (‘worst’) to five (‘best’). Mean scores
ranged from 1.8 (SD¼ 1.4) for ‘satisfaction when using the noisy
setting’, to 3.2 (SD¼ 1.6) for ‘ease of use’. The authors conclude
that overall acceptability of the TEO First device was low-to-
moderate. Mean duration of use was also measured, with partici-
pants reporting average daily use of 60minutes. Feasibility was
not reported by Reed et al. (2017).
Adverse effects
Sacco et al. (2016) explicitly reported that ‘no adverse events
were observed’ during the course of the study. Adverse effects
were not reported by Reed et al. (2017).
Remote microphone systems
Speech intelligibility
Six studies tested speech intelligibility. Summary effects and for-
est plots are provided in Supplemental 3 and Figure 2 respect-
ively. For all meta-analyses, heterogeneity was high (I2  80.3%),
and statistically significant (p 0.024).
Hearing aidsþ FM system vs. Unaided. Three studies (Lewis
et al. 2004, 2010; Rodemerk and Galster 2015) (n¼ 61 partici-
pants) showed that performance favoured the hearing aidsþ FM
system compared to unaided (Figure 2(B)).
Hearing aidsþ FM system vs. Hearing aid alone. Two studies
(Lewis et al. 2004; Rodemerk and Galster 2015) (n¼ 51 partici-
pants) showed that performance favoured the hearing aidsþ FM
system compared to hearing aids alone (Figure 2(C)).
Hearing aidsþ FM system vs. FM only. Three studies
(Rodemerk and Galster 2015; Lewis et al. 2010; Norrix et al.
2016) (n¼ 36 participants) showed that while performance fav-
oured FM microphone only compared to hearing aidsþ FM sys-
tem, the pooled effect was not significant (Figure 2(D)).
Hearing aidsþ FM system vs. Hearing aids þ2.4 GHz system.
Two studies (Rodemerk and Galster 2015; Thibodeau 2014)
(n¼ 27 participants) showed conflicting results, with one favour-
ing hearing aidsþ FM (Rodemerk and Galster 2015) and the
other favouring hearing aids þ2.4GHz system (Thibodeau 2014)
(Figure 2(E)).
Hearing aidsþBluetooth system vs. Hearing aids alone. Two
studies (Kim et al. 2014; Rodemerk and Galster 2015) (n¼ 46
participants) showed performance favoured the hearing
aidsþBluetooth system relative to the when the hearing aid was
used alone (Figure 2(F)).
Remote microphone only mode vs. Unaided or hearing aid
alone. Only one study (n¼ 16 participants) compared speech
intelligibility across four different remote microphone systems
(FM, Bluetooth, 900MHz wireless, 2.4 GHz wireless) (Rodemerk
and Galster 2015). All systems in microphone-only mode signifi-
cantly improved performance relative to both unaided and hear-
ing aid alone conditions (p< 0.001). The magnitude of this effect
did not differ statically between systems.
Figure 1. Selection of studies for the systematic review based on Preferred
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
flow diagram.
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Hearing-specific health-related QoL
There was no robust evidence as to whether remote microphone
systems improved self-reported hearing-specific health-related QoL.
Hearing aidsþ FM system vs. Hearing aids alone. Only one
study, using the MarkeTrak VI survey, compared the hearing
aidsþ FM system and hearing aids alone (Chisolm et al. 2007).
No statistically significant differences were found (six weeks,
n¼ 36, Z¼ 0.68, p¼ 0.499; one year, n¼ 30, Z¼ 0.71, p¼ 0.489).
Hearing aidsþBluetooth accessories vs. Hearing aids alone.
Only one study (n¼ 12 participants), using the International
Outcome Inventory for Hearing Aids (IOI-HA, Cox and
Alexander 2002), compared hearing aidsþBluetooth accessories
to hearing aids alone (Smith and Davis 2014). A statistically sig-
nificant improvement favouring hearing aidsþBluetooth acces-
sories was found for residual participation restrictions
(Z¼ 2.12, p¼ 0.034).
Listening ability
There was no robust evidence as to whether remote microphone
systems improved self-reported listening abilities.
Hearing aidsþ FM system vs. Hearing aids alone. Two studies
(Chisolm et al. 2007; Lewis et al. 2005) (n¼ 59 participants),
using different variants of the Communication Profile for the
Hearing Impaired (CPHI, Demorest and Erdman 1987), showed
that listening abilities were significantly better (p 0.03) for the
hearing aidsþ FM system compared to hearing aids alone for
social, work, and home situations.
Hearing aidsþBluetooth accessories vs. Hearing aids alone.
Only one study (n¼ 12 participants), using the IOI-HA, GHABP
and the Speech, Spatial and Qualities of Hearing Scale (SSQ,
Gatehouse and Noble 2004) (n¼ 12 participants), compared lis-
tening abilities between hearing aidsþBluetooth accessories and
hearing aids alone (Smith and Davis 2014). Statistically
Figure 2. Summary of the random effects meta-analyses for speech intelligibility: (A) PSAPs vs. unaided; (B) Hearing aidsþ FM system vs. Unaided; (C) Hearing
aidsþ FM system vs. Hearing aids alone; (D) Hearing aidsþ FM system vs. FM only; (E) Hearing aidsþ FM system vs. Hearing aids þ2.4GHz system; (F) Hearing
aidsþ Bluetooth system vs. Hearing aids alone. Black squares¼ summery effect size of each study for speech intelligibility. Error bars ¼95% confidence intervals (CI)
for the summery effects. Diamond¼ overall effect size, lateral points indicate 95% CI for overall effect estimate.
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significant improvements favouring hearing aidsþBluetooth
accessories were found for residual activity limitations (Z¼ 2.24,
p¼ 0.025) and residual disability (Z¼ 2.55, p¼ 0.011) subscales
(IOI-HA, GHABP). No statistically significant differences
(p 0.374) across all sub-scales were found between conditions
when listening abilities were measured using the SSQ.
Feasibility
Three different studies assessed the following feasibility domains:
(i) satisfaction (Chisolm et al. 2007); (ii) preferences (Thibodeau
2014); and (iii) usability (Smith and Davis 2014).
Hearing aidsþ FM system vs. Hearing aids alone. Using the
MarkeTrak VI survey, Chisolm et al. (2007) found statistically
significant improvements favouring the hearing aidsþ FM sys-
tem for satisfaction in ‘noisy’ listening situations (e.g. restaurant,
large group, leisure activities) (six weeks, n¼ 36, Z¼ 3.10,
p¼ 0.002; one year, n¼ 30, Z¼ 2.27, p¼ 0.007) and ‘ability to
hear soft sounds’ (six weeks, n¼ 36, Z¼ 3.31, p¼ 0.001; one
year, n¼ 30, Z¼ 3.25, p¼ 0.001).
Hearing aidsþ FM system vs. Hearing aids þ2.4 GHz system.
Thibodeau (2014) (n¼ 10 participants) found that all participants
reported that they preferred using hearing aids þ2.4GHz wire-
less system compared to hearing aidsþ FM system.
Hearing aidsþBluetooth accessories vs. Hearing aids alone.
Smith and Davis (2014) (n¼ 12 participants) observed that the
majority of participants (exact data not reported) reported that
Bluetooth accessories ‘quite easy’ to use and improved the quality
of sound when viewing the TV and using a cell phone.
Risk of bias assessment
Using the Cochrane risk of bias tool (Higgins and Green 2011),
all studies were judged to be high risk with regard to selection
bias (i.e. random sequence generation, allocation concealment)
due to the nature of the before-after study design (Table 1). Risk
of performance (blinding of participants/personnel) and detec-
tion bias (blinding of outcome assessment) was judged to be
high for ten and eight studies respectively, as no blinding proce-
dures were reported. Studies were judged to be low risk if blind-
ing was stated, although it should be acknowledged that blinding
in before-after studies is not always strictly possible as a conse-
quence of this study design. The risk of attrition bias due to
incomplete outcome data was judged to be low for all studies as
there was no attrition in nine studies. In the remaining two stud-
ies, while attrition ranged from 16.67% (Chisolm et al. 2007) to
25% (Smith and Davis 2014) at the one year and 12week
follow-up respectively, reasons for incomplete outcome data were
considered to be clearly reported in each article, increasing confi-
dence that missing data had no undue influence on the results.
With the exception of Reed et al. (2017), risk of reporting bias
(selective outcome reporting) was judged to be high for all stud-
ies, as numerical values were not sufficiently reported and/or
were only provided for statistically significant results. In terms of
risk of other bias, with the exception of three studies (Kim et al.
2014; Norrix et al. 2016; Reed et al. 2017), this was judged to be
unclear for seven studies because of financial support from the
manufacturer of the device(s) being evaluated. For one study
(Smith and Davis 2014), an author acted as a consultant for a
hearing aid manufacturer. For these reasons, potential vested
interest could have posed a threat to validity.
Quality assessment
Scores on the Downs and Black (1998) checklist ranged from 13
(Smith and Davis 2014) to 21 (Sacco et al. 2016) out of a pos-
sible total of 28, indicative of a poor to good level of quality
respectively. In terms of ‘reporting’, with the exception of one
study (Sacco et al. 2016), adverse effects as a consequence of the
intervention were not reported by any study. Whether partici-
pants were representative of the target population from which
they were recruited (i.e. ‘external validity’) was also uncertain
for the majority of studies, as sufficient detail was often lacking
to make a clear judgement. In terms of ‘internal validity’ (e.g.
randomisation, blinding), lower quality ratings arose because
no studies randomised participants to intervention groups.
Furthermore, only one study attempted to blind study partici-
pants to the intervention they received (Thibodeau 2014).
Similarly, a power calculation was reported for only one study
to determine sample size (Rodemerk and Galster 2015).
Discussion
In the current review, the scientific literature examining the
effectiveness of alternative listening devices in adults with mild
to moderate hearing loss was systematically searched. Eleven
studies met eligibility for inclusion, two studies evaluated
PSAPs and nine assessed remote microphone systems (FM,
Bluetooth, wireless). The majority of studies primarily exam-
ined behavioural measures of speech intelligibility in noise.
Self-reported hearing-specific QoL, listening ability and feasibil-
ity (i.e. usability, adherence, acceptability) were also evaluated,
but to a lesser extent. There were some outcomes of potential
interest that were not measured (i.e. cognition, general health-
related QoL, adverse effects). Follow-up ranged from one
month (Sacco et al. 2016) to one year (Chisolm et al. 2007),
with no long-term follow-up greater than one year. There was
considerable heterogeneity, whereby interventions and out-
comes varied greatly across studies. The evidence was judged to
be of poor to good quality, and subject to bias mainly due to
limitations in study design.
Table 1. Review authors’ judgements using Downs and Black (1998) checklist
to assess study quality for each included study, whereby higher scores indicate
superior study quality (total maximum score of 28).
Risk of bias
Study
Study
quality A B C D E F G
Sacco et al. (2016) 21 (good) High High High High Low High Unclear
Lewis et al. (2004) 20 (good) High High High High Low High Unclear
Lewis et al. (2005) 20 (good) High High High Low Low High Unclear
Chisolm et al. (2007) 19 (fair) High High High Low Low High Unclear
Lewis et al. (2010) 18 (fair) High High High High Low High Unclear
Rodemerk and
Galster (2015)
16 (fair) High High High High Low High Unclear
Thibodeau (2014) 16 (fair) High High Low Low Low High Unclear
Reed et al. (2017) 15 (fair) High High High High Low Low Low
Norrix et al. (2016) 14 (poor) High High High High Low High Low
Kim et al. (2014) 13 (poor) High High High High Low High Low
Smith and Davis (2014) 13 (poor) High High High High Low High Unclear
Risk of bias was assessed using the Cochrane risk of bias tool: A: sequence gen-
eration; B: allocation concealment; C: blinding of participants and personnel; D:
blinding of outcome assessors; E: incomplete outcome data; F: selective out-
come reporting; G: other sources of bias.
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Speech intelligibility
For speech intelligibility performance, data pooled across two
studies demonstrated that there was a beneficial effect of PSAPs
in improving performance compared to unaided conditions
(Reed et al. 2017; Sacco et al. 2016). Findings reported by Reed
et al. (2017) further suggest that this effect may be dependent on
the cost of the PSAP assessed, whereby PSAPs that were
pricedUS$299.99 improved speech intelligibility performance
relative to unaided and did not differ statistically from hearing
aids. A potential explanation for this finding may reside in exist-
ing evidence showing that higher priced PSAPs provide compar-
able electroacoustic characteristics to hearing aids (Callaway and
Punch 2008). However, the extent to which these variables (i.e.
price and/or electroacoustic characteristics) impact patient-
reported outcomes for PSAPs remains to be established.
Similarly, speech intelligibility performance was superior for
remote microphone systems used in conjunction with hearing
aids (FM, Bluetooth, wireless) relative to both unaided and hear-
ing aids alone (Kim et al. 2014; Lewis et al. 2004, 2010; Norrix
et al. 2016; Rodemerk and Galster 2015). While we can be confi-
dent in the direction of the effect, due to high heterogeneity, the
pooled effect size estimates could change with further evidence.
Heterogeneity between studies most likely arose as a consequence
of differences in assessment methodologies. In future, there
should be greater consistency in the outcome measures used to
assess speech intelligibility in adults with hearing loss.
Standardised measurement procedures should be employed
across studies so that they can be appropriately combined to
enable direct comparison of effect sizes.
Self-reported hearing-specific QoL, listening abilities and
feasibility
Outcome measures used to assess self-reported hearing-specific
QoL, listening abilities and feasibility varied considerably across
studies, as did duration of follow-up. This not only limited direct
comparison but may also help to explain why the pattern of
results was inconsistent across studies. On this basis, there is no
robust evidence as to whether alternative listening devices
included in this review improve these outcomes, or if the
improvements observed are specific to the device, situations
specified and/or outcome measures employed in each study. As a
consequence, we suggest that the same self-report outcome meas-
ures should be consistently applied across studies, which should
be appropriately sensitive and tap into the behavioural domains
that they aim to reflect (Ferguson et al. 2014, 2017; Heinrich,
Henshaw, and Ferguson 2016). There is a clear need for the
development of a core outcome set in audiological rehabilitation
research (Barker et al. 2015; Ferguson et al. 2017). In addition,
longer follow-up durations greater than one-year would improve
the certainty in the results, providing a better estimate of poten-
tial long-term benefit (Barker et al. 2016; Ferguson et al. 2017).
Study quality and risk of bias
The quality of the evidence included in this review was judged
to be poor to good and subject to bias. The design of all studies
was classified as ‘observational’ (i.e. before-after comparison),
with no studies employing a separate control group. As a result,
confidence in the effect size estimates are limited, as the true
effects may be different. It cannot be known with certainty
whether the effects seen are due to the devices, rather than due
to regression to the mean or external factors affecting all partici-
pants. Further high-quality evidence is, therefore, required to
improve confidence in the effect size estimates.
It should be noted that no studies assessing Smartphone-con-
nected hearing aids or Smartphone ‘hearing aid’ apps met the
inclusion criteria during the article screening process. We are
aware of at least one non-peer reviewed publication that has
evaluated Smartphone hearing aid apps compared to conven-
tional hearing aids (Amlani et al. 2013). This study was not
detected in the current review because it was published in an
industry-related magazine (i.e. the grey literature). Inclusion of
the grey literature could have provided a broader review of the
available evidence. However, we opted to exclude databases of
the grey literature in our pre-specified search strategy because
there is no agreed method of extracting and synthesising evi-
dence obtained from this literature in a clear and transparent
way. This would also reduce, though not eliminate, the likeli-
hood of including poor quality studies. Two of the study authors
(DM, MF) worked collaboratively with the UK NIHR Horizon
Scanning and Intelligence Centre to review new and emerging
technologies for hearing loss (NIHR Horizon Scanning Research
and Intelligence Centre 2017). Together with the current system-
atic review, and Cochrane review on hearing aids for mild to
moderate hearing loss (Ferguson et al. 2017), all three reviews
provide up-to-date high-level evidence of a wide range of listen-
ing devices.
Review limitations
A potential limitation of this review, as well as the field more
generally, is that there is no consensus in terms of audiometric
descriptors across different countries and organisations. In this
review, we used the audiometric descriptors for mild to moderate
hearing loss, based on pure-tone air-conduction thresholds estab-
lished by the British Society of Audiology (2011). An average
hearing threshold in the better hearing ear across octave frequen-
cies 0.25–4 kHz that are 20 and 40 dB HL is defined as ‘mild’,
and 41 and 70 dB HL as ‘moderate’. Other definitions adopt
different frequency ranges and intensity cut-offs, such as the
World Health Organisation definitions, whereby average thresh-
olds across 0.5–4 kHz between 26 and 40 dB HL is defined as
‘mild’, and 41 to 60 dB HL as ‘moderate’ hearing loss (Mathers,
Smith, and Concha 2000). In addition, individual hearing thresh-
old data were seldom reported for all included studies and could
not be made available by the study authors for logistical reasons.
Although unlikely, included studies could have included some
participants with more severe degrees of hearing loss.
Nevertheless, in accordance with our published protocol
(Maidment et al. 2016), studies were verified as eligible for inclu-
sion because the mean average hearing threshold always fell
within the pre-specified range.
Research recommendations
On the basis of this review, further high-quality evidence, namely
randomised controlled trials (RCTs), is needed to evaluate
whether alternative listening devices are a clinically- and cost-
effective intervention for adults living with hearing loss. This is
in-line with a research recommendation for hearing loss assess-
ment and management specified by the UK National Institute
for Clinical Excellence (2018). Such research has also been iden-
tified as a high-priority need in the US (Humes et al. 2017;
National Academies of Science 2016), given that alternative
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listening devices could enable new service delivery models (e.g.
direct-to-consumer, over-the-counter). Moreover, there have
been recent legislative changes in the United States, with the
introduction of the Over-the-Counter (OTC) Hearing Aid Act of
2017, which aim to improve accessibility and affordability of
hearing-healthcare for adults. High-quality evidence, therefore, is
needed as a priority in this area. In a recently published rando-
mised, double-blind, placebo-controlled clinical trial (Humes
et al. 2017), hearing aids fitted by an audiologist (i.e. ‘audiology
best practices’) and hearing aids fitted using an OTC model
resulted in similar effect sizes for measures of speech recognition
and hearing aid benefit. Nevertheless, satisfaction and percentage
likely to purchase hearing aids post-trial were lower for the OTC
model, potentially attributable to the lack of audiological inter-
action during the provision of the hearing aids (Humes et al.
2017). It has been proposed that adults living with hearing loss
may require optional assistance to successfully use alternative lis-
tening devices that do not require a hearing healthcare profes-
sional in terms of device fitting and/or fine-tuning (Keidser and
Convery 2016). In support, the results of our mixed-methods
usability study, completed following this systematic review, sug-
gest that people living with hearing loss would like greater
instruction to use and adjust alternative listening devices them-
selves (Maidment and Ferguson 2017, Forthcoming). Remotely-
delivered information is one means of providing such assistance,
and has been shown to successfully supplement the provision of
hearing aids, resulting in improved outcomes (Ferguson et al.
2016; Kramer et al. 2005; Thoren et al. 2014). Therefore, we rec-
ommend that this concept be incorporated in the design of
future effectiveness trials.
Conclusions
In summary, the evidence included in this review suggests that
alternative listening devices improve behavioural measures of
speech intelligibility relative to unaided and/or conventional
hearing aids. There is no robust evidence as to whether alterna-
tive listening devices improve self-reported outcomes.
Furthermore, the evidence was judged to be poor to good quality
and subject to bias due to limitations in study design. On this
basis, we argue that high-quality studies (i.e. RCTs) investigating
the clinical- and cost-effectiveness of alternative listening devices
are needed in this area. Such evidence, though currently unavail-
able, is necessary to guide healthcare commissioners and policy-
makers when considering new service delivery pathways to
benefit adults living with hearing loss. Moreover, given that this
field is likely to continue to develop in new and unexpected
ways, we envisage that the current systematic review will require
updating, and it is our intention to do so in two to three years.
These rapid developments reflect the innovative nature of the
field, which not only has the potential to transform hearing
healthcare service delivery in the future but also increase the
likelihood that people will seek and use amplification to success-
fully manage their hearing loss.
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